Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bodor

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
Journal of Ocular Pharmacology|January 1, 1994
Designing safer ophthalmic drugs by soft drug approachesN Bodor
Annals of the New York Academy of Sciences|January 1, 1987
Redox drug delivery systems for targeting drugs to the brainN Bodor
Acta Pharmaceutica Nordica|January 1, 1989
Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiolT Loftsson, N Bodor
Journal of Pharmaceutical Sciences|July 1, 1981
Improved delivery through biological membranes IX: Kinetics and mechanism of hydrolysis of methylsulfinymethyl 2-acetoxybenzoate and related aspirin prodrugsT Loftsson, N Bodor
Pharmaceutical Research|August 1, 1995
Quantitative structure activity relationships of catechol derivatives on nerve growth factor secretion in L-M cellsA Kourounakis, N Bodor
The Journal of Pharmacy and Pharmacology|August 24, 2001
A simple, predictive, structure-based skin permeability modelP Buchwald, N Bodor
Acta Pharmaceutica Nordica|January 1, 1990
The effect of phosphine oxides on transdermal deliveryN Bodor, T Loftsson
Die Pharmazie|April 11, 2000
Cardiovascular studies on different classes of soft drugsA Juhász, N Bodor
Journal of Receptor and Signal Transduction Research|January 5, 2002
Drug targeting by retrometabolic design: soft drugs and chemical delivery systemsN Bodor, P Buchwald
Die Pharmazie|July 10, 2010
Recent advances in retrometabolic drug design (RMDD) and developmentN Bodor, P Buchwald
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Journal of Ocular Pharmacology|January 1, 1994
Designing safer ophthalmic drugs by soft drug approachesN Bodor
Annals of the New York Academy of Sciences|January 1, 1987
Redox drug delivery systems for targeting drugs to the brainN Bodor
Acta Pharmaceutica Nordica|January 1, 1989
Effects of 2-hydroxypropyl-beta-cyclodextrin on the aqueous solubility of drugs and transdermal delivery of 17 beta-estradiolT Loftsson, N Bodor
Journal of Pharmaceutical Sciences|July 1, 1981
Improved delivery through biological membranes IX: Kinetics and mechanism of hydrolysis of methylsulfinymethyl 2-acetoxybenzoate and related aspirin prodrugsT Loftsson, N Bodor
Pharmaceutical Research|August 1, 1995
Quantitative structure activity relationships of catechol derivatives on nerve growth factor secretion in L-M cellsA Kourounakis, N Bodor
The Journal of Pharmacy and Pharmacology|August 24, 2001
A simple, predictive, structure-based skin permeability modelP Buchwald, N Bodor
Acta Pharmaceutica Nordica|January 1, 1990
The effect of phosphine oxides on transdermal deliveryN Bodor, T Loftsson
Die Pharmazie|April 11, 2000
Cardiovascular studies on different classes of soft drugsA Juhász, N Bodor
Journal of Receptor and Signal Transduction Research|January 5, 2002
Drug targeting by retrometabolic design: soft drugs and chemical delivery systemsN Bodor, P Buchwald
Die Pharmazie|July 10, 2010
Recent advances in retrometabolic drug design (RMDD) and developmentN Bodor, P Buchwald
Pageof 21